{"pmid":32352202,"title":"Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate Coronavirus Disease 2019.","text":["Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate Coronavirus Disease 2019.","BACKGROUND: The clinical presentation of European patients with mild-to-moderate Covid-19 infection is still unknown. OBJECTIVE: To study the clinical presentation of Covid-19 in Europe. METHODS: Patients with positive diagnosis of Covid-19 were recruited from 18 European hospitals. Epidemiological and clinical data were obtained through a standardized questionnaire. Bayesian analysis was used for analyzing the relationship between outcomes. RESULTS: 1,420 patients completed the study (962 females, 30.7% of health care workers). The mean age of patients was 39.17+/-12.09 years. The most common symptoms were headache (70.3%), loss of smell (70.2%), nasal obstruction (67.8%), cough (63.2%), asthenia (63.3%), myalgia (62.5%), rhinorrhea (60.1%), gustatory dysfunction (54.2%) and sore throat (52.9%). Fever was reported by on 45.4%. The mean duration of Covid-19 symptoms of mild-to-moderate cured patients was 11.5+/-5.7 days. The prevalence of symptoms significantly varied according to age and sex. Young patients more frequently had ear, nose, and throat complaints, whereas elderly individuals often presented fever, fatigue and loss of appetite. Loss of smell, headache, nasal obstruction and fatigue were more prevalent in female patients. The loss of smell was a key symptom of mild-to-moderate Covid19 patients and was not associated with nasal obstruction and rhinorrhea. Loss of smell persisted at least 7 days after the disease in 37.5% of cured patients. CONCLUSION: The clinical presentation of mild-to-moderate Covid-19 substantially varies according to the age and the sex characteristics of patients. Olfactory dysfunction seems to be an important underestimated symptom of mild-to-moderate Covid-19 that needs to be recognized as such by the WHO.","J Intern Med","Lechien, Jerome R","Chiesa-Estomba, Carlos M","Place, Sammy","Van Laethem, Yves","Cabaraux, Pierre","Mat, Quentin","Huet, Kathy","Plzak, Jan","Horoi, Mihaela","Hans, Stephane","Barillari, Maria Rosaria","Cammaroto, Giovanni","Fakhry, Nicolas","Martiny, Delphine","Ayad, Tareck","Jouffe, Lionel","Hopkins, Claire","Saussez, Sven","32352202"],"abstract":["BACKGROUND: The clinical presentation of European patients with mild-to-moderate Covid-19 infection is still unknown. OBJECTIVE: To study the clinical presentation of Covid-19 in Europe. METHODS: Patients with positive diagnosis of Covid-19 were recruited from 18 European hospitals. Epidemiological and clinical data were obtained through a standardized questionnaire. Bayesian analysis was used for analyzing the relationship between outcomes. RESULTS: 1,420 patients completed the study (962 females, 30.7% of health care workers). The mean age of patients was 39.17+/-12.09 years. The most common symptoms were headache (70.3%), loss of smell (70.2%), nasal obstruction (67.8%), cough (63.2%), asthenia (63.3%), myalgia (62.5%), rhinorrhea (60.1%), gustatory dysfunction (54.2%) and sore throat (52.9%). Fever was reported by on 45.4%. The mean duration of Covid-19 symptoms of mild-to-moderate cured patients was 11.5+/-5.7 days. The prevalence of symptoms significantly varied according to age and sex. Young patients more frequently had ear, nose, and throat complaints, whereas elderly individuals often presented fever, fatigue and loss of appetite. Loss of smell, headache, nasal obstruction and fatigue were more prevalent in female patients. The loss of smell was a key symptom of mild-to-moderate Covid19 patients and was not associated with nasal obstruction and rhinorrhea. Loss of smell persisted at least 7 days after the disease in 37.5% of cured patients. CONCLUSION: The clinical presentation of mild-to-moderate Covid-19 substantially varies according to the age and the sex characteristics of patients. Olfactory dysfunction seems to be an important underestimated symptom of mild-to-moderate Covid-19 that needs to be recognized as such by the WHO."],"journal":"J Intern Med","authors":["Lechien, Jerome R","Chiesa-Estomba, Carlos M","Place, Sammy","Van Laethem, Yves","Cabaraux, Pierre","Mat, Quentin","Huet, Kathy","Plzak, Jan","Horoi, Mihaela","Hans, Stephane","Barillari, Maria Rosaria","Cammaroto, Giovanni","Fakhry, Nicolas","Martiny, Delphine","Ayad, Tareck","Jouffe, Lionel","Hopkins, Claire","Saussez, Sven"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352202","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/joim.13089","keywords":["europe","clinical","coronavirus","covid-19","epidemiological","medicine","patients","symptoms"],"locations":["myalgia"],"topics":["Diagnosis"],"weight":1,"_version_":1666138495700172800,"score":9.490897,"similar":[{"pmid":32253535,"pmcid":"PMC7134551","title":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.","text":["Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.","OBJECTIVE: To investigate the occurrence of olfactory and gustatory dysfunctions in patients with laboratory-confirmed COVID-19 infection. METHODS: Patients with laboratory-confirmed COVID-19 infection were recruited from 12 European hospitals. The following epidemiological and clinical outcomes have been studied: age, sex, ethnicity, comorbidities, and general and otolaryngological symptoms. Patients completed olfactory and gustatory questionnaires based on the smell and taste component of the National Health and Nutrition Examination Survey, and the short version of the Questionnaire of Olfactory Disorders-Negative Statements (sQOD-NS). RESULTS: A total of 417 mild-to-moderate COVID-19 patients completed the study (263 females). The most prevalent general symptoms consisted of cough, myalgia, and loss of appetite. Face pain and nasal obstruction were the most disease-related otolaryngological symptoms. 85.6% and 88.0% of patients reported olfactory and gustatory dysfunctions, respectively. There was a significant association between both disorders (p < 0.001). Olfactory dysfunction (OD) appeared before the other symptoms in 11.8% of cases. The sQO-NS scores were significantly lower in patients with anosmia compared with normosmic or hyposmic individuals (p = 0.001). Among the 18.2% of patients without nasal obstruction or rhinorrhea, 79.7% were hyposmic or anosmic. The early olfactory recovery rate was 44.0%. Females were significantly more affected by olfactory and gustatory dysfunctions than males (p = 0.001). CONCLUSION: Olfactory and gustatory disorders are prevalent symptoms in European COVID-19 patients, who may not have nasal symptoms. The sudden anosmia or ageusia need to be recognized by the international scientific community as important symptoms of the COVID-19 infection.","Eur Arch Otorhinolaryngol","Lechien, Jerome R","Chiesa-Estomba, Carlos M","De Siati, Daniele R","Horoi, Mihaela","Le Bon, Serge D","Rodriguez, Alexandra","Dequanter, Didier","Blecic, Serge","El Afia, Fahd","Distinguin, Lea","Chekkoury-Idrissi, Younes","Hans, Stephane","Delgado, Irene Lopez","Calvo-Henriquez, Christian","Lavigne, Philippe","Falanga, Chiara","Barillari, Maria Rosaria","Cammaroto, Giovanni","Khalife, Mohamad","Leich, Pierre","Souchay, Christel","Rossi, Camelia","Journe, Fabrice","Hsieh, Julien","Edjlali, Myriam","Carlier, Robert","Ris, Laurence","Lovato, Andrea","De Filippis, Cosimo","Coppee, Frederique","Fakhry, Nicolas","Ayad, Tareck","Saussez, Sven","32253535"],"abstract":["OBJECTIVE: To investigate the occurrence of olfactory and gustatory dysfunctions in patients with laboratory-confirmed COVID-19 infection. METHODS: Patients with laboratory-confirmed COVID-19 infection were recruited from 12 European hospitals. The following epidemiological and clinical outcomes have been studied: age, sex, ethnicity, comorbidities, and general and otolaryngological symptoms. Patients completed olfactory and gustatory questionnaires based on the smell and taste component of the National Health and Nutrition Examination Survey, and the short version of the Questionnaire of Olfactory Disorders-Negative Statements (sQOD-NS). RESULTS: A total of 417 mild-to-moderate COVID-19 patients completed the study (263 females). The most prevalent general symptoms consisted of cough, myalgia, and loss of appetite. Face pain and nasal obstruction were the most disease-related otolaryngological symptoms. 85.6% and 88.0% of patients reported olfactory and gustatory dysfunctions, respectively. There was a significant association between both disorders (p < 0.001). Olfactory dysfunction (OD) appeared before the other symptoms in 11.8% of cases. The sQO-NS scores were significantly lower in patients with anosmia compared with normosmic or hyposmic individuals (p = 0.001). Among the 18.2% of patients without nasal obstruction or rhinorrhea, 79.7% were hyposmic or anosmic. The early olfactory recovery rate was 44.0%. Females were significantly more affected by olfactory and gustatory dysfunctions than males (p = 0.001). CONCLUSION: Olfactory and gustatory disorders are prevalent symptoms in European COVID-19 patients, who may not have nasal symptoms. The sudden anosmia or ageusia need to be recognized by the international scientific community as important symptoms of the COVID-19 infection."],"journal":"Eur Arch Otorhinolaryngol","authors":["Lechien, Jerome R","Chiesa-Estomba, Carlos M","De Siati, Daniele R","Horoi, Mihaela","Le Bon, Serge D","Rodriguez, Alexandra","Dequanter, Didier","Blecic, Serge","El Afia, Fahd","Distinguin, Lea","Chekkoury-Idrissi, Younes","Hans, Stephane","Delgado, Irene Lopez","Calvo-Henriquez, Christian","Lavigne, Philippe","Falanga, Chiara","Barillari, Maria Rosaria","Cammaroto, Giovanni","Khalife, Mohamad","Leich, Pierre","Souchay, Christel","Rossi, Camelia","Journe, Fabrice","Hsieh, Julien","Edjlali, Myriam","Carlier, Robert","Ris, Laurence","Lovato, Andrea","De Filippis, Cosimo","Coppee, Frederique","Fakhry, Nicolas","Ayad, Tareck","Saussez, Sven"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32253535","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s00405-020-05965-1","keywords":["anosmia","covid","covid-19","coronavirus","dysgeusia","ent","gustatory","hyposmia","infection","loss","olfaction","olfactory","sars-cov-2","smell","taste"],"locations":["myalgia"],"topics":["Diagnosis"],"weight":1,"_version_":1666138493164716032,"score":378.65186},{"pmid":32423357,"title":"Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.","text":["Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.","OBJECTIVE: Olfactory dysfunction (OD)-hyposmia or anosmia-is a symptom of coronavirus disease 2019 (COVID-19), caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We sought to better determine prevalence, severity, and timing of OD in COVID-19 relative to other sinonasal and pulmonary symptoms. STUDY DESIGN: Prospective, cross-sectional. SETTING: Regional/cantonal hospital. SUBJECTS: In total, 103 patients diagnosed with COVID-19 with reverse transcription polymerase chain reaction (RT-PCR)-based testing. METHODS: All patients testing positive for COVID-19 at Kantonsspital Aarau over a 6-week period were approached. Timing and severity (at its worst, on scale of 0 [none], 1 [mild], 2 [moderate], and 3 [severe]) of OD, loss of taste, nasal obstruction, rhinorrhea/mucus production, fever, cough and shortness of breath (SOB) were assessed for each patient. RESULTS: Prevalence of OD was 61.2%, and severity of OD was strongly correlated with severity of loss of taste experienced (rho = 0.87, P < .001). OD was experienced on the first day of COVID-19 by 8.7% and overall occurred at median infection day 3 (mean, 3.4; range, 0-12). Most experiencing OD reported anosmia, and mean severity of all with OD was moderate to severe (mean [SD], 2.7 [0.6]). Nasal obstruction (49.5%) and rhinorrhea (35.0%) were frequently reported but not correlated with OD. SOB was more severe in patients with OD. OD was associated negatively with older age (OR, 0.96; 95% CI, 0.93-0.99; P = .007) and positively with female sex (OR, 2.46; 95% CI, 0.98-6.19; P = .056). CONCLUSIONS: OD is highly prevalent during COVID-19, occurring early and severely, often in conjunction with loss of taste. OD is associated negatively with older age and positively with female sex. Patients with OD may also experience more severe SOB.","Otolaryngol Head Neck Surg","Speth, Marlene M","Singer-Cornelius, Thirza","Obere, Michael","Gengler, Isabelle","Brockmeier, Steffi J","Sedaghat, Ahmad R","32423357"],"abstract":["OBJECTIVE: Olfactory dysfunction (OD)-hyposmia or anosmia-is a symptom of coronavirus disease 2019 (COVID-19), caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We sought to better determine prevalence, severity, and timing of OD in COVID-19 relative to other sinonasal and pulmonary symptoms. STUDY DESIGN: Prospective, cross-sectional. SETTING: Regional/cantonal hospital. SUBJECTS: In total, 103 patients diagnosed with COVID-19 with reverse transcription polymerase chain reaction (RT-PCR)-based testing. METHODS: All patients testing positive for COVID-19 at Kantonsspital Aarau over a 6-week period were approached. Timing and severity (at its worst, on scale of 0 [none], 1 [mild], 2 [moderate], and 3 [severe]) of OD, loss of taste, nasal obstruction, rhinorrhea/mucus production, fever, cough and shortness of breath (SOB) were assessed for each patient. RESULTS: Prevalence of OD was 61.2%, and severity of OD was strongly correlated with severity of loss of taste experienced (rho = 0.87, P < .001). OD was experienced on the first day of COVID-19 by 8.7% and overall occurred at median infection day 3 (mean, 3.4; range, 0-12). Most experiencing OD reported anosmia, and mean severity of all with OD was moderate to severe (mean [SD], 2.7 [0.6]). Nasal obstruction (49.5%) and rhinorrhea (35.0%) were frequently reported but not correlated with OD. SOB was more severe in patients with OD. OD was associated negatively with older age (OR, 0.96; 95% CI, 0.93-0.99; P = .007) and positively with female sex (OR, 2.46; 95% CI, 0.98-6.19; P = .056). CONCLUSIONS: OD is highly prevalent during COVID-19, occurring early and severely, often in conjunction with loss of taste. OD is associated negatively with older age and positively with female sex. Patients with OD may also experience more severe SOB."],"journal":"Otolaryngol Head Neck Surg","authors":["Speth, Marlene M","Singer-Cornelius, Thirza","Obere, Michael","Gengler, Isabelle","Brockmeier, Steffi J","Sedaghat, Ahmad R"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32423357","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1177/0194599820929185","keywords":["covid-19","sars-cov-2","sars-cov2","anosmia","coronavirus","gustatory dysfunction","gustatory function","hyposmia","nasal obstruction","olfaction","olfactory dysfunction","olfactory function","rhinorrhea","smell","taste"],"locations":["Prevalence"],"topics":["Diagnosis"],"weight":1,"_version_":1667252837786058753,"score":228.9701},{"pmid":32437033,"title":"Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.","text":["Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.","OBJECTIVE: To investigate olfactory dysfunction (OD) in patients with mild coronavirus disease 2019 (COVID-19) through patient-reported outcome questionnaires and objective psychophysical testing. METHODS: COVID-19 patients with self-reported sudden-onset OD were recruited. Epidemiological and clinical data were collected. Nasal complaints were evaluated with the sinonasal outcome-22. Subjective olfactory and gustatory status was evaluated with the National Health and Nutrition Examination Survey. Objective OD was evaluated using psychophysical tests. RESULTS: Eighty-six patients completed the study. The most common symptoms were fatigue (72.9%), headache (60.0%), nasal obstruction (58.6%), and postnasal drip (48.6%). Total loss of smell was self-reported by 61.4% of patients. Objective olfactory testings identified 41 anosmic (47.7%), 12 hyposmic (14.0%), and 33 normosmic (38.3%) patients. There was no correlation between the objective test results and subjective reports of nasal obstruction or postnasal drip. CONCLUSION: A significant proportion of COVID-19 patients reporting OD do not have OD on objective testing.","Head Neck","Lechien, Jerome R","Cabaraux, Pierre","Chiesa-Estomba, Carlos M","Khalife, Mohamad","Hans, Stephane","Calvo-Henriquez, Christian","Martiny, Delphine","Journe, Fabrice","Sowerby, Leigh","Saussez, Sven","32437033"],"abstract":["OBJECTIVE: To investigate olfactory dysfunction (OD) in patients with mild coronavirus disease 2019 (COVID-19) through patient-reported outcome questionnaires and objective psychophysical testing. METHODS: COVID-19 patients with self-reported sudden-onset OD were recruited. Epidemiological and clinical data were collected. Nasal complaints were evaluated with the sinonasal outcome-22. Subjective olfactory and gustatory status was evaluated with the National Health and Nutrition Examination Survey. Objective OD was evaluated using psychophysical tests. RESULTS: Eighty-six patients completed the study. The most common symptoms were fatigue (72.9%), headache (60.0%), nasal obstruction (58.6%), and postnasal drip (48.6%). Total loss of smell was self-reported by 61.4% of patients. Objective olfactory testings identified 41 anosmic (47.7%), 12 hyposmic (14.0%), and 33 normosmic (38.3%) patients. There was no correlation between the objective test results and subjective reports of nasal obstruction or postnasal drip. CONCLUSION: A significant proportion of COVID-19 patients reporting OD do not have OD on objective testing."],"journal":"Head Neck","authors":["Lechien, Jerome R","Cabaraux, Pierre","Chiesa-Estomba, Carlos M","Khalife, Mohamad","Hans, Stephane","Calvo-Henriquez, Christian","Martiny, Delphine","Journe, Fabrice","Sowerby, Leigh","Saussez, Sven"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437033","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/hed.26279","keywords":["covid-19","anosmia","coronavirus","evaluation","olfaction","olfactory","smell","taste"],"topics":["Diagnosis"],"weight":1,"_version_":1667521393817812993,"score":218.16403},{"pmid":32474850,"title":"Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study.","text":["Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study.","Clinical features of COVID-19 have been mostly described in hospitalized patients with and without ICU admission. Yet, up to 80% of patients are managed in an outpatient setting. This population is poorly documented. In France, health authorities recommend outpatient management of patients presenting mild-to-moderate COVID-19 symptoms. The aim of this study was to describe their clinical characteristics. The study took place in an emergency medical dispatching center located in the Greater Paris region. Patients included in this survey met confirmed COVID-19 infection criteria according to the WHO definition. We investigated clinical features and classified symptoms as general, digestive, ear-nose-throat, thoracic symptoms, and eye disease. Patients were included between March 24 and April 6 2020. 1487 patients included: 700 (47%) males and 752 (51%) females, with a median age of 44 (32-57) years. In addition to dry cough and fever reported in more than 90% of cases, the most common symptoms were general symptoms: body aches/myalgia (N = 845; 57%), headache (N = 824; 55%), and asthenia (N = 886; 60%); shortness of breath (N = 479; 32%) and ear-nose-throat symptoms such as anosmia (N = 415; 28%) and ageusia (N = 422; 28%). Chest pain was reported in 320 (21%) cases and hemoptysis in 41 (3%) cases. The main difference between male and female patients was an increased prevalence of ear-nose-throat symptoms as well as diarrhea, chest pains, and headaches in female patients. General symptoms and ear-nose-throat symptoms were predominant in COVID-19 patients presenting mild-to-moderate symptoms. Shortness of breath and chest pain were remarkably frequent.","Intern Emerg Med","Lapostolle, Frederic","Schneider, Elodie","Vianu, Isabelle","Dollet, Guillaume","Roche, Bastien","Berdah, Julia","Michel, Julie","Goix, Laurent","Chanzy, Erick","Petrovic, Tomislav","Adnet, Frederic","32474850"],"abstract":["Clinical features of COVID-19 have been mostly described in hospitalized patients with and without ICU admission. Yet, up to 80% of patients are managed in an outpatient setting. This population is poorly documented. In France, health authorities recommend outpatient management of patients presenting mild-to-moderate COVID-19 symptoms. The aim of this study was to describe their clinical characteristics. The study took place in an emergency medical dispatching center located in the Greater Paris region. Patients included in this survey met confirmed COVID-19 infection criteria according to the WHO definition. We investigated clinical features and classified symptoms as general, digestive, ear-nose-throat, thoracic symptoms, and eye disease. Patients were included between March 24 and April 6 2020. 1487 patients included: 700 (47%) males and 752 (51%) females, with a median age of 44 (32-57) years. In addition to dry cough and fever reported in more than 90% of cases, the most common symptoms were general symptoms: body aches/myalgia (N = 845; 57%), headache (N = 824; 55%), and asthenia (N = 886; 60%); shortness of breath (N = 479; 32%) and ear-nose-throat symptoms such as anosmia (N = 415; 28%) and ageusia (N = 422; 28%). Chest pain was reported in 320 (21%) cases and hemoptysis in 41 (3%) cases. The main difference between male and female patients was an increased prevalence of ear-nose-throat symptoms as well as diarrhea, chest pains, and headaches in female patients. General symptoms and ear-nose-throat symptoms were predominant in COVID-19 patients presenting mild-to-moderate symptoms. Shortness of breath and chest pain were remarkably frequent."],"journal":"Intern Emerg Med","authors":["Lapostolle, Frederic","Schneider, Elodie","Vianu, Isabelle","Dollet, Guillaume","Roche, Bastien","Berdah, Julia","Michel, Julie","Goix, Laurent","Chanzy, Erick","Petrovic, Tomislav","Adnet, Frederic"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474850","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s11739-020-02379-z","keywords":["covid-19","clinical feature","epidemic","out-patient"],"locations":["France","Paris"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Diagnosis"],"weight":1,"_version_":1668341932734021633,"score":211.21938},{"pmid":32360780,"title":"Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19.","text":["Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19.","OBJECTIVES: Detailed knowledge on the prevalence of asymptomatic cases of COVID-19 and the clinical characteristics of mild COVID-19 is essential for effective control of the COVID-19 pandemic. We determined the prevalence of asymptomatic cases of COVID-19 and characterized the symptoms of patients with mild COVID-19. METHODS: We recruited the study participants from a community facility designated for isolation of patients without moderate-to-severe symptoms of COVID-19 in South Korea. The prevalence of asymptomatic patients at admission and the detailed symptoms of mild COVID-19 were evaluated through a questionnaire-based survey. Diagnosis of COVID-19 was confirmed by real-time RT-PCR. RESULTS: Of the 213 patients with COVID-19, 41 (19.2%) were asymptomatic until admission. Among the remaining patients with mild COVID-19, the most common symptom was cough (40.1% [69/172]), followed by hyposmia (39.5% [68/172]) and sputum (39.5%, [68/172]). Of the 68 patients with hyposmia, 61 (90%) patients had accompanying symptoms such as hypogeusia, nasal congestion, or rhinorrhea. Fever (>37.5 degrees C) was only observed in 20 (11.6%). CONCLUSIONS: As much as one-fifth of patients with COVID-19 had remained asymptomatic from exposure to admission. Hyposmia was quite frequent among patients with mild COVID-19, whereas fever was not. Social distancing should be strongly implemented to prevent disease transmission from asymptomatic patients or those with mild and inconspicuous symptoms.","Clin Microbiol Infect","Kim, Gwang-Un","Kim, Min-Jae","Ra, Sang Hyun","Lee, Jeongsoo","Bae, Seongman","Jung, Jiwon","Kim, Sung-Han","32360780"],"abstract":["OBJECTIVES: Detailed knowledge on the prevalence of asymptomatic cases of COVID-19 and the clinical characteristics of mild COVID-19 is essential for effective control of the COVID-19 pandemic. We determined the prevalence of asymptomatic cases of COVID-19 and characterized the symptoms of patients with mild COVID-19. METHODS: We recruited the study participants from a community facility designated for isolation of patients without moderate-to-severe symptoms of COVID-19 in South Korea. The prevalence of asymptomatic patients at admission and the detailed symptoms of mild COVID-19 were evaluated through a questionnaire-based survey. Diagnosis of COVID-19 was confirmed by real-time RT-PCR. RESULTS: Of the 213 patients with COVID-19, 41 (19.2%) were asymptomatic until admission. Among the remaining patients with mild COVID-19, the most common symptom was cough (40.1% [69/172]), followed by hyposmia (39.5% [68/172]) and sputum (39.5%, [68/172]). Of the 68 patients with hyposmia, 61 (90%) patients had accompanying symptoms such as hypogeusia, nasal congestion, or rhinorrhea. Fever (>37.5 degrees C) was only observed in 20 (11.6%). CONCLUSIONS: As much as one-fifth of patients with COVID-19 had remained asymptomatic from exposure to admission. Hyposmia was quite frequent among patients with mild COVID-19, whereas fever was not. Social distancing should be strongly implemented to prevent disease transmission from asymptomatic patients or those with mild and inconspicuous symptoms."],"journal":"Clin Microbiol Infect","authors":["Kim, Gwang-Un","Kim, Min-Jae","Ra, Sang Hyun","Lee, Jeongsoo","Bae, Seongman","Jung, Jiwon","Kim, Sung-Han"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32360780","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.cmi.2020.04.040","locations":["South Korea"],"countries":["Korea, Republic of"],"countries_codes":["KOR|Korea, Republic of"],"topics":["Diagnosis","Prevention","Transmission"],"weight":1,"_version_":1666138495534497792,"score":200.59564}]}